
NASDAQHealthcareMedical - Care Facilities
最新数据
US$9.37
+US$0.04 · +0.43%
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
前收盘价
US$9.37
+US$0.04 · +0.43%
盘前
US$9.37
US$0.00 · 0.00%
10月8日 7:58 ET
盘中时间采用ET。市场数据可能有所延迟。
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
日内区间
当前US$9.37
52周区间
当前US$9.37
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
买入
估值
68
低估
情绪
56
多空交织
风险
27
中等风险
动量
69
动能增强
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
日内区间
当前US$9.37
52周区间
当前US$9.37
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 2.7亿 USD | 2.24亿 USD | 1.83亿 USD | 1.39亿 USD | 1.17亿 USD |
| 销货成本 | 1.15亿 USD | 9105.4万 USD | 7022.5万 USD | 5415.2万 USD | 4365.2万 USD |
| 毛利 | 1.55亿 USD | 1.33亿 USD | 1.13亿 USD | 8468万 USD | 7341万 USD |
| 研究与开发 | 301.7万 USD | 306.8万 USD | 278.2万 USD | 269.6万 USD | 211万 USD |
| 销售、一般及管理费用 | 1.3亿 USD | 1.12亿 USD | 9373.3万 USD | 7336.3万 USD | 6004.3万 USD |
| 营业费用 | 1.35亿 USD | 1.15亿 USD | 9845.3万 USD | 7642.8万 USD | 6183万 USD |
| 利息支出 | 118.2万 USD | 77.6万 USD | 42.4万 USD | 19.7万 USD | 31.8万 USD |
| 折旧和摊销 | 2861.3万 USD | 2536.8万 USD | 2186.2万 USD | 1563万 USD | 1131.2万 USD |
| 营业利润 | 2071万 USD | 1790万 USD | 1433万 USD | 825.2万 USD | 1158万 USD |
| 净利润 | 1493.4万 USD | 1126.5万 USD | 1024.3万 USD | 622.2万 USD | 912.6万 USD |
公司数据更新于 2026年10月8日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
iShares Russell 2000 ETFIWM822.59万0.01%785.63亿 USD0.19%US$277.7-1.29%
Vanguard Morningstar Total Stock Market ETFVTI806.84万0.00%2.3万亿 USD0.03%US$381.03-0.40%
Vanguard Extended Market ETFVXF346.2万0.00%954亿 USD0.05%US$233.49-1.56%
iShares Russell 2000 Growth ETFIWO301.58万0.02%142.49亿 USD0.24%US$355.37-1.43%
Vanguard Russell 2000 ETFVTWO172.89万0.01%180亿 USD0.06%US$112.21-1.26%
iShares Micro-Cap ETFIWC99.05万0.07%13.33亿 USD0.60%US$183.36-1.09%
Vanguard Russell 2000 Growth ETFVTWG32.56万0.02%17亿 USD0.06%US$259.28-1.46%
Invesco RAFI US 1500 Small-Mid ETFPRFZ22.85万0.01%26.84亿 USD0.36%US$52.73-1.20%
iShares Russell 2000 ETFIWM
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Russell 2000 Growth ETFIWO
Vanguard Russell 2000 ETFVTWO
iShares Micro-Cap ETFIWC
Vanguard Russell 2000 Growth ETFVTWG
Invesco RAFI US 1500 Small-Mid ETFPRFZAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。